Mirae Asset Global ETFs Holdings
APLS

Mirae Asset Global ETFs Holdings’s Apellis Pharmaceuticals APLS Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,788
Closed -$219K – 3177
2026
Q1 		$219K Buy
12,788
+2,744
+27% +$59.1K ﹤0.01% 2317
2025
Q4 		$254K Buy
10,044
+1,435
+17% +$33.7K ﹤0.01% 2238
2025
Q3 		$195K Sell
8,609
-32,375
-79% -$755K ﹤0.01% 2335
2025
Q2 		$710K Buy
40,984
+11,425
+39% +$211K ﹤0.01% 1624
2025
Q1 		$667K Buy
29,559
+19,944
+207% +$551K ﹤0.01% 1709
2024
Q4 		$307K Buy
9,615
+1,578
+20% +$47.5K ﹤0.01% 2158
2024
Q3 		$237K Sell
8,037
-1,161
-13% -$43K ﹤0.01% 2291
2024
Q2 		$382K Buy
+9,198
New +$417K ﹤0.01% 1944

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's APLS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 12,788 shares — an estimated $219K sold.

Mirae Asset Global ETFs Holdings first reported a position in APLS in Q2 2024 and held it in 8 quarters. The position peaked at $710K in Q2 2025. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 12,788 Apellis Pharmaceuticals shares in Q2 2026, an estimated $219K.
  • Mirae Asset Global ETFs Holdings first reported a position in Apellis Pharmaceuticals in Q2 2024 and held it in 8 quarters.
  • Mirae Asset Global ETFs Holdings's Apellis Pharmaceuticals position peaked at $710K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.